| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 03 Jan 2024 |  Extraordinary General Meeting | NA | 03 Jan 2024 | 10.02 | 8.92 |
| 12 Feb 2024 |  Rights | 13:12 | 12 Feb 2024 | 9.81 | 12.51 |
| 27 Aug 2024 |  Annual General Meeting | NA | 27 Aug 2024 | 7.73 | 8.89 |
| 11 Dec 2024 |  Quarterly Result Announcement | NA | 11 Dec 2024 | 7.74 | 7.74 |
| 04 Apr 2025 | Extraordinary General Meeting | NA | 04 Apr 2025 | 13.38 | 14.76 |
| 07 Jul 2025 | Quarterly Result Announcement | NA | 07 Jul 2025 | 23.28 | 24.13 |
| 30 Aug 2025 | Annual General Meeting | NA | 30 Aug 2025 | 20.20 | 19.00 |
| 19 Nov 2025 | Quarterly Result Announcement | NA | 19 Nov 2025 | 19.90 | 17.22 |
Dipna Pharmachem
17.00
+1.49
(9.61%)
Key Fundamentals
Market Cap
40.88 Cr
EPS
0.41
PE Ratio
37.83
Dividend Yield
0.00 %
Industry
Healthcare 52 Week High
26.31
52 Week Low
6.54
PB Ratio
0.97
Debt to Equity
0.48
Sector
Pharmaceuticals Actual
Company News
View All News
Dipna Pharmachem Limited Non-Executive Director Nirav Soni Resigns1 day ago
Nirav Soni (DIN: 08317653) resigned from his position as Non-Executive Director of Dipna Pharmachem Limited effective November 19, 2025, citing pre-occupation with other work and assignments. The Board acknowledged his valuable contributions during his tenure, and Soni confirmed there are no material reasons for his resignation beyond those stated in his resignation letter.
Dipna Pharmachem Allots 2.82 Crore Convertible Warrants at Rs 13.05 Per ShareSep 12, 2025
Dipna Pharmachem Limited's Board approved and allotted 2,81,58,500 convertible warrants to promoter and non-promoter categories on a preferential basis. Each warrant is convertible into one equity share within 18 months at Rs 13.05 per share. The warrants were allotted to 11 individuals including Dipna Keyur Shah (80,67,500 warrants) and Kajal Ashok Jain (94,11,000 warrants). Upon conversion of all 5,80,32,500 warrants (including previously allotted warrants), the company's paid-up share capital will increase from Rs 24.05 crore to Rs 82.08 crore, with total equity shares rising from 2.40 crore to 8.21 crore shares.
Dipna Pharmachem Allots 2.99 Crore Convertible Warrants at Rs 13.05 Each on Preferential Basis
Sep 09, 2025
Sep 09, 2025Dipna Pharmachem Limited's Board of Directors approved and allotted 2,98,74,000 convertible warrants at Rs 13.05 per warrant to promoter and non-promoter categories on a preferential basis. Each warrant can be converted into one equity share with a face value of Rs 10 within 18 months from the allotment date. The warrants were issued for cash consideration with a premium of Rs 3.05 per warrant. The allotment includes 23 allottees, with the largest allocations going to Keyur Dipakkumar Shah (96,00,000 warrants) and Ashok Dilipkumar Jain (94,02,000 warrants). The total 25% consideration amount collected is Rs 9,74,63,925. The remaining 75% of the issue price must be paid before exercising the conversion option.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,782.00 | #1 4,27,561.49 | 40.68 | #1 54,729.00 | 9.71 | #1 10,980 | 2.89 | 71.49 | |
6,390.50 | 1,69,647.70 | 69.05 | 9,712.00 | 18.67 | 2,191 | 35.10 | 47.34 | |
3,687.30 | 1,24,794.99 | 58.80 | 11,539.40 | 6.99 | 1,911 | 30.46 | 54.89 | |
1,517.90 | 1,22,608.99 | 22.73 | 28,409.50 | 7.12 | 5,291 | 3.71 | 48.01 | |
1,247.40 | 1,04,109.72 | #1 18.15 | 33,741.20 | 16.73 | 5,725 | -0.38 | 53.56 | |
926.35 | 93,212.49 | 18.56 | 23,511.00 | 18.55 | 4,615 | 34.60 | 33.23 | |
2,032.60 | 92,839.92 | 21.34 | 22,909.50 | 13.74 | 3,306 | #1 72.75 | 58.77 | |
2,242.00 | 92,540.45 | 52.05 | 12,744.20 | #1 20.90 | 2,007 | -21.05 | 32.96 | |
1,210.70 | 70,317.65 | 20.70 | 32,345.60 | 9.43 | 3,484 | 3.81 | 63.26 | |
5,694.00 | 68,080.31 | 28.29 | 13,458.30 | 3.70 | 2,216 | 10.98 | 60.35 |
Growth Rate
Revenue Growth
-23.98 %
Net Income Growth
-9.09 %
Cash Flow Change
-69.56 %
ROE
-12.46 %
ROCE
6.30 %
EBITDA Margin (Avg.)
32.06 %
Corporate Action
Technical Indicators
RSI(14)
Neutral 24.28
ATR(14)
Volatile 1.03
STOCH(9,6)
Neutral 20.94
STOCH RSI(14)
Oversold 0.00
MACD(12,26)
Bearish -0.39
ADX(14)
Weak Trend 16.35
UO(9)
Bearish 49.69
ROC(12)
Downtrend And Accelerating -22.06
WillR(14)
Oversold -100.00
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
